Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Psychopharmacology (Berl). 2011 Mar 15;216(4):511–523. doi: 10.1007/s00213-011-2239-y

Table 1.

Pharmacokinetics of hydromorphone (0.1 mg/kg hydromorphone HCl) i.v. to rhesus (n=5)

Parameter Low Median High Geometric mean
AUCExtrapolated % 3.2 4.2 14.9 5.3
AUC0-LAST h ng mL–1 19.1 34.4 44.6 32.5
AUC0-INF h ng mL–1 22.4 35.9 46.3 34.8
AUMC0-INF h hng mL–1 21.7 39.4 61.6 38.7
AUMC0-LAST h hng mL–1 11.1 31.3 46.1 28.4
C0 ng mL–1 29.7 35.9 41.5 35.6
Cl mL min–1 kg–1 32.1 41.3 66.3 42.7
T ½ λ z h 0.8 0.9 1.0 0.9
λ z h–1 0.669 0.798 0.841 0.777
MRT0-INF h 1.0 1.1 1.4 1.1
MRT0-LAST h 0.6 0.9 1.1 0.9
Vss L kg–1 2.1 2.7 3.9 2.8
Vz L kg–1 2.4 3.3 4.7 3.3
T ½ Biologic h 0.4 0.7 0.8 0.6

AUC0-INF the area under the curve from time 0 to infinity, AUC0-LAST area under the curve from 0 to the last time point, AUCExtrapolated percent of the AUC extrapolated to infinity, AUMC0-INF area under the first moment curve from time 0 to infinity, AUMC0-LAST area under the first moment curve from time 0 to the last measured time point, Cl serum clearance, Vss apparent volume of distribution at steady state, Vz apparent volume of distribution of the area during the elimination phase, λz first-order rate constant, T½ λz terminal half-life, MRT0-INF mean residence time extrapolated to infinity, MRT0-last mean residence time from 0 to the last measured time point, C0 the concentration extrapolated to time 0, CMAX maximum serum concentration, TMAX time to maximum serum concentration, Vz F–1 Vz per fraction of the dose absorbed